Kentaro Minagawa

ORCID

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 7

Top Venues

Annals of hematology

American journal of hematology

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Seema Naik, Baldeep Wirk, Witold Rybka, Christopher Ehmann, Brooke Silar, Caitlin Vajdic, Neal Shah, Leonard Tuanquin, Robert Greiner, Valerie Brown, Raymond Hohl, David Claxton, Shin Mineishi, Kentaro Minagawa, Hiroko Shike
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis. Annals of hematology (2022)
Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Seema Naik, Baldeep Wirk, Witold Rybka, Christopher Ehmann, Brooke Silar, Caitlin Vajdic, Neal Shah, Leonard Tuanquin, Robert Greiner, Valerie Brown, Raymond Hohl, David Claxton, Shin Mineishi, Kentaro Minagawa, Hiroko Shike
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis. Annals of hematology 102 (3) (2022)
Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Seema Naik, Baldeep Wirk, Witold Rybka, Christopher Ehmann, Brooke Silar, Caitlin Vajdic, Neal Shah, Leonard Tuanquin, Robert Greiner, Valerie Brown, Raymond Hohl, David Claxton, Shin Mineishi, Kentaro Minagawa, Hiroko Shike
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis. Annals of hematology 102 (3) (2022)
Christopher J Pizzola, Joseph Cioccio, Kevin L Rakszawski, Myles Nickolich, W Christopher Ehmann, Witold B Rybka, Baldeep Wirk, Seema G Naik, Hong Zheng, Brooke Silar, Hiroko Shike, Shouhao Zhou, Shin Mineishi, Kentaro Minagawa, David F Claxton
Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities. Bone marrow transplantation 57 (11) (2022)
Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Seema Naik, Baldeep Wirk, Witold Rybka, Christopher Ehmann, Brooke Silar, Caitlin Vajdic, Neal Shah, Leonard Tuanquin, Robert Greiner, Valerie Brown, Raymond Hohl, David Claxton, Shin Mineishi, Kentaro Minagawa, Hiroko Shike
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis. Annals of hematology 102 (3) (2022)
Neal Shah, Kevin Rakszawski, Myles Nickolich, Christopher Ehmann, Baldeep Wirk, Seema Naik, Witold Rybka, Hong Zheng, Joseph Mierski, Brooke Silar, Gina Mackey, Robert Greiner, Valerie Brown, David Claxton, Shin Mineishi, Kentaro Minagawa
Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion. Annals of hematology 100 (10) (2021)
Omer H Jamy, Raquel Innis-Shelton, Susan Bal, Ravi Paluri, Donna Salzman, Antonio Di Stasi, Luciano José Megale Costa, Ruby Meredith, Lawrence Lamb, Kentaro Minagawa, Shin Mineishi, Ayman Saad
Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation. American journal of hematology 96 (10) (2021)

Kentaro Minagawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kentaro Minagawa